The legacy of Viagra and its parent , copyright, presents a complex picture for potential investors. While the blockbuster drug initially produced enormous revenues , its patent has lapsed , leading to generic options flooding the market . This decline in value knockoff presents a real hurdle for copyright and any portfolio considering a significan